OzempicSemaglutide · GLP-1 receptor agonist

Ozempic is licensed in the UK for type 2 diabetes, not for weight management, so the lawful route is a prescription for that indication from a prescriber who has assessed you, dispensed by a registered pharmacy. If you are seeking treatment for weight rather than diabetes, Wegovy and Mounjaro are the licensed options and are the ones to ask about.

Each of those routes puts an assessment in front of the supply, and that is what separates them from everything else. A website that will sell you Ozempic without assessing you is operating outside the law, and the contents of what arrives cannot be verified.

You can check a UK pharmacy before you buy. Registered pharmacies appear on the General Pharmaceutical Council register, and registered online pharmacies display the MHRA distance selling logo as a link back to the regulator. A logo that is only a picture is not a registration.

A clinical assessment first, covering medical history, current medication, height and weight, and any weight-related conditions. A prescriber then reviews it independently and decides whether Ozempic is appropriate.

Weight-management medicines are classed as high-risk, so the prescriber has to verify what you have reported rather than accept the form as submitted. That means a photograph, a video call, or contact with your GP. A provider that omits that step is not following the regulator's rules.

The answer can be no, and some assessments end without a prescription. That is the process working.

Four checks. The pharmacy is on the GPhC register. It names its superintendent pharmacist. It shows the MHRA distance selling logo as a working link. And it will not supply without an assessment.

One signal matters more here than on any other page: a provider offering to supply Ozempic for weight loss is prescribing outside its licence at a time of sustained shortage, which the MHRA has asked prescribers not to do because it removes supply from people with diabetes who depend on it.

Sellers on social media, marketplaces and messaging apps are not licensed suppliers whatever their listing says. Falsified semaglutide has been found in UK supply chains and seized by the MHRA, and counterfeit packaging is usually better than people expect.

Only from a registered pharmacy, and only after a clinical assessment and a prescription. Searching "ozempic buy online" returns plenty of sites willing to skip both; none of them is a lawful supplier, and what arrives from them cannot be verified for identity, strength or sterility.

A legitimate online pharmacy looks different in one specific way: it will not let you reach a checkout before a prescriber has decided. If you can add Ozempic to a basket, you are not on a pharmacy site.

Searching "ozempic reviews" mostly returns individual accounts, and those are worth reading for what treatment feels like week to week: nausea after a dose increase, appetite changes, what people found manageable.

What reviews cannot tell you is whether Ozempic is appropriate for you. Response varies considerably between people, and a review is a sample of one with no information about the reader. The trial data on this page is the part that generalises; the reviews are the part that does not.

Cost varies by dose, provider and market. It is worth saying plainly that cost is the wrong reason to choose Ozempic over a licensed weight-management treatment, because the licensed options have been studied for this use and this one has not.

The reason no figure appears on this page is specific: prescription-only medicines cannot be advertised to the public in the UK, and a published price is advertising. You are quoted after assessment, once the dose is known. A site that shows you a price for Ozempic before assessing you is telling you it does not follow that rule.

What is worth comparing before you commit is what the price includes. Whether follow-up reviews are covered, whether dose increases cost more, whether prescriber contact is charged separately, and what happens if you stop.